Proven Ability to Succeed
Almost a century ago, alliance partners at the University of Toronto helped us produce the world's first commercial insulin product. Many years later, we worked with Genentech to bring the world its first human health biotech product—human insulin.
We're still going strong, with collaborations that span the entire pharmaceutical value chain. Our partners represent the wide range of discovery, development, and commercialization sources available, including academia, startups and larger firms, and other parties that ensure therapies are available to patients in need. The emergence of the global knowledge economy is exciting, and we're doing all we can to work with partners wherever they may be.
About Our Partnerships
To foster and harness the power of innovation, we are dedicated to finding and leveraging the true diversity—of perspective, capability, and geography—that exists among our collaborators. The result is mutually beneficial partnerships that bring the best medicines to market.
Learn more about our current partnerships:
"In the tradition of outstanding collaborations that brought products like Actos®, Byetta®, and Cialis® to market, dynamic partnerships are at work across Lilly's entire value chain. What makes these alliances great is a dedication to aligning our strengths—and our actions—in a way that results in shared success for the entire collaboration team."
Gino Santini
Senior Vice President, Corporate Strategy and Business Development
